Sign in: Staff/Students
The University of Liverpool has been awarded £8 million by the National Institute for Health Research (NIHR) to support two Health Protection Research Units (HPRUs), one in Emerging and Zoonotic Infections and the other in Gastrointestinal Infections. These new awards will allow a continuation of the first HPRUs, which ran from 2014 to 2020.
The HPRU in Emerging and Zoonotic Infections, led by Professor Tom Solomon, continues the partnership between the University of Liverpool, Liverpool School of Tropical Medicine and Public Health England, and is enhanced by the addition of University of Oxford. It will have three major programmes, building on the work of the last six years: one focusing on imported mosquito-borne threats such as Zika and dengue; one addressing tick-borne diseases endemic in the UK such as Lyme; and one tackling high consequence infectious diseases, such as Ebola. The team are currently heavily involved in supporting the UK’s response to the novel coronavirus outbreak, which began at the end of December 2019 and is spreading across the globe.
The HPRU in Gastrointestinal Infections, led by Professor Miren Iturriza-Gómara, continues the partnership between the University of Liverpool, and Public Health England, and is enhanced by the addition of the University of Warwick. Its objectives are to reduce the burden of gastrointestinal infections and health inequalities by deploying emerging technologies in data science and genomics to identify the drivers of disease experienced by particular communities and targeting effective interventions, based on societal values.
Professor Louise Kenny, Executive Pro-Vice-Chancellor for the Faculty of Health and Life Sciences, said: “I’m delighted that Liverpool has once again received this funding from NIHR to host these important Health Protection Research Units in Infection. It underscores Liverpool’s pre-eminence at the forefront of infectious diseases research in the UK.
“Indeed, Dame Sally Davies, former Chief Medical Officer and our UK antimicrobial resistance (AMR) Special Envoy who visited Liverpool last week to celebrate the foundation of a Chair of AMR Research named in her honour, said that Liverpool is leading the way in combating the threat of infectious diseases on the global stage.”
A total of 14 new HPRUs were announced today by NIHR, as part of a £58.7 million research investment to keep the public safe from current and emerging public health threats. The HPRUs, which are all partnerships between top universities and Public Health England, will launch in April and run for five years.
Health Minister Nicola Blackwood said: “The UK’s achievements in public health to date have saved the lives of millions of people. This would have been impossible without world-leading research conducted by some of brightest minds up and down the country.
“The latest round of NIHR’s Health Protection Research Units, which have previously played a pivotal role in responding to major events such as the Novichok and Ebola incidents, will continue protect the health of the public and reduce inequalities – helping us all live healthier lives.”
All recent news
New UK coronavirus measures introduced
Obituary: Dr Stephan Pfaffenzeller
Analysis reveals impact of poverty and family adversity on adolescent health
£1.6m study aims to understand why COVID-19 vaccines can lead to rare instances of blood clotting with low platelets
Arrangements for industrial action 1 – 3 December
Persistent poverty and/or persistent poor parental mental health affects over four in ten children in UK today, @LivUni-led analysis finds ➡️ https://bit.ly/3xButtM
£1.6m programme led by @MPUoL seeks to understand the very rare, but very serious, condition of blood clotting with low platelets in the general population, in #COVID19 infection & potentially following vaccination ➡️ https://bit.ly/3o5GtR1
Professor Tom Solomon, Director of the UK’s Emerging Infections Research Unit tells #BBCBreakfast more cases of Omicron are expected to be found in the UK.
Six more cases of the new coronavirus variant have been identified in Scotland.